Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:36:35 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Z:CRL - CHARLES RIVER LABORATORIES - http://www.criver.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRL - Z5.0229.31·230.975.0230.09-2.35-1.0499.8114,6207,310234.40  234.40  229.85275.00  161.65Apr 17Apr 1615 min RT 2¢

Recent Trades - Last 10 of 7310
Time ETExPriceChangeVolume
17:17:17Z230.09-2.25139
16:37:28Z228.01-4.334
16:32:15Z185.00-47.347
16:32:15Z229.86-2.482
16:20:00Z230.09-2.25270
16:02:01Z230.09-2.2521
16:01:59Z230.09-2.2542
16:01:54Z230.09-2.25252
16:01:49Z230.09-2.2527
16:01:31Z230.09-2.2545,000

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-16 08:00U:CRLNews ReleaseCharles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing
2024-04-12 08:00U:CRLNews ReleaseCharles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call
2024-04-11 08:00U:CRLNews ReleaseCharles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
2024-04-09 08:00U:CRLNews ReleaseCharles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
2024-04-04 08:00U:CRLNews ReleaseCharles River to Perform Plasmid Production for Ship of Theseus
2024-04-01 08:00U:CRLNews ReleaseCharles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
2024-03-27 08:00U:CRLNews ReleaseCharles River Laboratories Publishes 2023 Corporate Citizenship Report
2024-03-21 08:00U:CRLNews ReleaseCharles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine
2024-03-14 08:00U:CRLNews ReleaseCharles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration
2024-03-12 08:00U:CRLNews ReleaseCharles River Laboratories to Present at Barclays Global Healthcare Conference
2024-02-29 02:00U:CRLNews ReleaseWheeler Bio Seals Agreement with Charles River to Offer Portable CMC(TM) to Discovery Clients to Accelerate Their Journey to First-in-Human Use
2024-02-21 08:00U:CRLNews ReleaseCharles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing
2024-02-20 08:08U:CRLNews ReleaseCharles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells
2024-02-14 07:00U:CRLNews ReleaseCharles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance
2024-01-29 08:00U:CRLNews ReleaseCharles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test
2024-01-24 16:30U:CRLNews ReleaseCharles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors
2024-01-23 16:30U:CRLNews ReleaseCharles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call
2024-01-16 08:00U:CRLNews ReleaseCharles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing
2024-01-08 08:00U:CRLNews ReleaseCharles River Laboratories to Present at J.P. Morgan Healthcare Conference